Proxy form for use at the 2026 first extraordinary general meeting to be held on October 9, 2026
Filed with HKEX · Stock code 2185 · · 1 page · English
as my/our proxy of (Note 3) to attend and vote for me/us and on my/our behalf as directed below at the 2026 first extraordinary general meeting (the “Meeting”) of the Company to be held at Room 302, 3/F, Building 4, No. 590 Ruiqing Road, East Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, PRC at 2:00 p.m. on October 9, 2026 or at any adjournment thereof. Please make a mark in the appropriate
Shanghai Bio-Heart Biological Technology Co., Ltd. on 6ix
Earlier from Shanghai Bio-Heart Biological Technology
- Proposed appointment of independent non-executive director; and (2) notice of 2026 first extraordinary general meeting
- Notice of 2026 first extraordinary general meeting
- Announcement pursuant to rule 13.51B(2) of the listing rules
- Voluntary announcement strategic cooperation agreement with shanghai shenqi medical technology co., ltd. to advance the commercialisation of the bioheart bioabsorbable rapamycin-eluting coronary stent system
- Articles of association
Later from Shanghai Bio-Heart Biological Technology
- 2026 Interim report
- Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 September 2026
- (1) Poll results of the 2026 first extraordinary general meeting held on October 9, 2026; (2) resignation of independent non-executive director; (3) appointment of independent non-executive director; and (4) change of composition of board committees
- List of directors and their roles and functions
- Adoption of the china accounting standards for business enterprises for the preparation of financial reports on a uniform basis and proposed change of auditor
Follow Shanghai Bio-Heart Biological Technology into a list and get an email when it puts out news.
Follow Shanghai Bio-Heart Biological Technology